Novo Nordisk A/S

Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood…

Global stocks have seen a stellar run in 2025, yet widening performance gaps and rising expectations suggest the…

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill…

Daniel Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy…

A view shows The World Health Organization (WHO) headquarters in Geneva, Switzerland, Jan. 28, 2025. Denis Balibouse |…

Sopa Images | Lightrocket | Getty Images This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in…

In the battle between weight-loss drug companies, Eli Lilly has emerged as the clear winner for investors. The…

Global stocks have fluctuated wildly over the past week, as concerns about AI valuations hang over equity markets.…

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024.…

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…

The city of Lisbon in Portugal turns to tech next week, as it plays host to the annual…

US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC…

Novo Nordisk beyond weight loss has investors wary, scientists hopeful